176 related articles for article (PubMed ID: 23283958)
1. Evolution of CD8+ T cell responses after acute PARV4 infection.
Simmons R; Sharp C; Levine J; Bowness P; Simmonds P; Cox A; Klenerman P
J Virol; 2013 Mar; 87(6):3087-96. PubMed ID: 23283958
[TBL] [Abstract][Full Text] [Related]
2. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.
Simmons R; Sharp C; Sims S; Kloverpris H; Goulder P; Simmonds P; Bowness P; Klenerman P
J Infect Dis; 2011 May; 203(10):1378-87. PubMed ID: 21502079
[TBL] [Abstract][Full Text] [Related]
3. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
[TBL] [Abstract][Full Text] [Related]
6. Parvovirus 4 infection and clinical outcome in high-risk populations.
Simmons R; Sharp C; McClure CP; Rohrbach J; Kovari H; Frangou E; Simmonds P; Irving W; Rauch A; Bowness P; Klenerman P;
J Infect Dis; 2012 Jun; 205(12):1816-20. PubMed ID: 22492853
[TBL] [Abstract][Full Text] [Related]
7. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
[TBL] [Abstract][Full Text] [Related]
8. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
Maple PA; Beard S; Parry RP; Brown KE
Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
[TBL] [Abstract][Full Text] [Related]
9. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.
Tamošiūnas PL; Simutis K; Kodzė I; Firantienė R; Emužytė R; Petraitytė-Burneikienė R; Zvirblienė A; Sasnauskas K
Intervirology; 2013; 56(5):271-7. PubMed ID: 23941824
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus PARV4 visualization and detection.
Tuke PW; Parry RP; Appleton H
J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
[TBL] [Abstract][Full Text] [Related]
12. Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.
Chen MY; Hung CC; Lee KL
Virol J; 2015 Jun; 12():94. PubMed ID: 26088443
[TBL] [Abstract][Full Text] [Related]
13. Antigenicity study of the yeast-generated human parvovirus 4 (PARV4) virus-like particles.
Lazutka J; Simutis K; Matulis P; Petraitytė-Burneikienė R; Kučinskaitė-Kodzė I; Simanavičius M; Tamošiunas PL
Virus Res; 2021 Jan; 292():198236. PubMed ID: 33242523
[TBL] [Abstract][Full Text] [Related]
14. PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort.
Sharp CP; Gregory WF; Hattingh L; Malik A; Adland E; Daniels S; van Zyl A; Carlson JM; Wareing S; Ogwu A; Shapiro R; Riddell L; Chen F; Ndung'u T; Goulder PJR; Klenerman P; Simmonds P; Jooste P; Matthews PC
Wellcome Open Res; 2017 Apr; 2():26. PubMed ID: 28497124
[No Abstract] [Full Text] [Related]
15. No evidence of presence of parvovirus 4 in a Swedish cohort of severely immunocompromised children and adults.
Tolfvenstam T; Norbeck O; Ohrmalm L
PLoS One; 2012; 7(9):e46430. PubMed ID: 23050026
[TBL] [Abstract][Full Text] [Related]
16. Frequency of human parvovirus 4 (PARV4) viremia among HBV-infected patients and healthy donors in Shiraz, Iran.
Amirahmadi F; Sarvari J; Hosseini SY; Pirbonyeh N; Gorzin AA
Turk J Med Sci; 2017 Jun; 47(3):868-873. PubMed ID: 28618736
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
Manning A; Willey SJ; Bell JE; Simmonds P
J Infect Dis; 2007 May; 195(9):1345-52. PubMed ID: 17397006
[TBL] [Abstract][Full Text] [Related]
18. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
[TBL] [Abstract][Full Text] [Related]
19. Human parvovirus 4 infection, Cameroon.
Lavoie M; Sharp CP; Pépin J; Pennington C; Foupouapouognigni Y; Pybus OG; Njouom R; Simmonds P
Emerg Infect Dis; 2012 Apr; 18(4):680-3. PubMed ID: 22469425
[TBL] [Abstract][Full Text] [Related]
20. Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.
Kasprowicz V; Isa A; Tolfvenstam T; Jeffery K; Bowness P; Klenerman P
J Virol; 2006 Nov; 80(22):11209-17. PubMed ID: 16943301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]